T
TORL BioTherapeutics, LLC
1 follower
A clinical-stage biopharmaceutical company advancing the development of new biologics for cancer treatment. TORL-Bio was founded in 2018 and is focused on the development of novel antibody-based therapeutics for cancer patients. TORL has currently 3 therapeutics in Ph1 clinical trials in indicatio... Read more
Org chart
Mark Alles
Chief Executive Officer
Collapse
Dave Licata
President And CFO TORL Biotherapeutics / Executive Chairman 1200 Pharma
Amir Naiberg
Board Observer
Aran Maree M.d.
Chief Medical Officer
Bilqees Akhtar
Vice President, Head Of Regulatory Affairs
Iris Sison
Associate Vice President Clinical Operations
Teams
Offices
This company has no offices yet